PGL 0.00% 44.5¢ prospa group limited.

just ignore whatever tobago (tharlow) says. he has no clue what...

  1. 19 Posts.
    just ignore whatever tobago (tharlow) says. he has no clue what he's talking about......somrtimes the things he says are so wrong i think he's taking the piss or having a joke.

    if tobago did know about liver cancer, he be aware that treatment as an adjuvent to surgery and treatment of non-operable liver cancer are DIFFERENT INDICATIONS.

    PI-88 WILL BE THE FIRST DRUG APPROVED TO TREAT PRIMARY LIVER CANCER AS AN ADJUNCT TO SURGERY

    NEXAVAR WILL BE APPROVED TO TREAT ADVANCED (INOPERABLE) LIVER CANCER

    NOTE: PI-88 has a much better safety profile than nexavar........nexavars safety profile makes it VERY UNLIKELY that the drug WILL EVER be a serious adjunct treatment...

    These two indications are like chalk and cheese!


    If you only remember one thing from this post, remember that tobago is totally uninformed. he's probably a plumber.
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.